Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04ABS
|
||||
Former ID |
DIB002742
|
||||
Drug Name |
CPH-102
|
||||
Synonyms |
IABP; CPH-102; INH2BP, Crimson Pharmaceutical; INH2BP, Octamer; PARP inhibitors, Crimson Pharmaceutical; PARP inhibitors, Octamer; CPH-101, Crimson Pharma
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Preclinical | [546143] | ||
Company |
Octamer Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c12ccc(=O)oc1ccc(c2I)N
|
||||
CAS Number |
CAS 137881-27-7
|
||||
Target and Pathway | |||||
Target(s) | Poly [ADP-ribose] polymerase-1 | Target Info | Inhibitor | [543709] | |
KEGG Pathway | Base excision repair | ||||
NF-kappa B signaling pathway | |||||
PANTHER Pathway | FAS signaling pathway | ||||
Pathway Interaction Database | Integrin-linked kinase signaling | ||||
Caspase Cascade in Apoptosis | |||||
Notch-mediated HES/HEY network | |||||
Reactome | Dual Incision in GG-NER | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.